RSSTrial Methodology

Editor’s Message: September–October 2016 Issue Highlights

Editor’s Message: September–October 2016 Issue Highlights

| October 9, 2016 | 0 Comments

Dear Colleagues: Welcome to the September-October 2016 issue of Innovations in Clinical Neuroscience (ICNS). As the official journal of the CNS Summit, the International Society for CNS Drug Development (ISCDD), and the International Society for CNS Clinical Trials and Methodology (ISCTM), an important part of our editorial mission is to accelerate and enhance the development […]

Continue Reading

Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers:  A Pilot Study

Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study

| October 9, 2016 | 0 Comments

by Glen P. Flores, PhD; Brian Peace, BS; Tony C. Carnes, PhD; Susan L. Baumgartner, PharmD, MBA; D. Eric Buffkin, Jr., MBA; Neil R. Euliano, PhD; and Larry N. Smith, MD, FACS Drs. Flores, Carnes, Euliano, Mr. Peace, and Mr. Buffkin are with etectRx, Inc. in Newberry, Florida; and Drs. Baumgartner and Smith are from […]

Continue Reading

Assessment of Cognitive and Neurologic Recovery in Ischemic Stroke Drug Trials: Results from a Randomized, Double-blind, Placebo-controlled Study

Assessment of Cognitive and Neurologic Recovery in Ischemic Stroke Drug Trials: Results from a Randomized, Double-blind, Placebo-controlled Study

| October 9, 2016 | 0 Comments

by Franco Di Cesare, MD; Jessica Mancuso, PhD; Brian Silver, MD; and Peter T. Loudon, PhD Dr. Di Cesare is with Leoben Research Limited in Glasgow, UK; Dr. Mancuso is with Research Statistics at Pfizer in Groton, Connecticut, USA; Dr. Silver is with Rhode Island Hospital and Alpert Medical School of Brown University in Providence, Rhode […]

Continue Reading

The Standard for Clinicians’ Interview in Psychiatry (SCIP):  A Clinician-administered Tool with Categorical, Dimensional, and Numeric Output— Conceptual Development, Design, and Description of the SCIP

The Standard for Clinicians’ Interview in Psychiatry (SCIP): A Clinician-administered Tool with Categorical, Dimensional, and Numeric Output— Conceptual Development, Design, and Description of the SCIP

| June 1, 2016 | 0 Comments

by Ahmed Aboraya, MD, DrPh; Henry Nasrallah, MD; Srinivas Muvvala, MD, MPH; Ahmed El-Missiry, MD, MRCPsych, IFAPA; Hader Mansour, MD, PhD; Cheryl Hill, MD PhD; Daniel Elswick, MD; and Elizabeth C. Price, PhD Dr. Aboraya is Chief of Psychiatry at William R. Sharpe Jr. Hospital, Clinical Professor of Psychiatry at West Virginia School of Osteopathic […]

Continue Reading

The Neuroscience Report—Volume 41 (May 20, 2016): Human Brain vs. Artificial Intelligence

The Neuroscience Report—Volume 41 (May 20, 2016): Human Brain vs. Artificial Intelligence

| May 20, 2016 | 0 Comments

The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s […]

Continue Reading

Hot Topics in Drug Development

Hot Topics in Drug Development

| April 3, 2016 | 0 Comments

Hot Topics in Drug Development PDFs can be downloaded and printed from the e-Editions. Click on the above issue issue, find the article, then click on the print command. For archived e-editions, click on the image above, then click on the folder icon at the top of the window.

Continue Reading

Editor’s Message and Issue Highlights

Editor’s Message and Issue Highlights

| April 1, 2016 | 0 Comments

Dear Colleagues: Welcome to the March–April 2016 issue of Innovations in Clinical Neuroscience (ICNS). Attitudes regarding marijuana use have changed dramatically over the past 50-plus years in the United States. According to data from the Pew Research Center, support for the legalization of marijuana has gone from 12 percent of the American population in favor […]

Continue Reading